Abrar Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abrar Ahmed has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Abhay K. Kattepur
Department of Surgical Oncology, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, India
2 shared publications Gopinath Ks
Sri Devaraj Urs Academy of Higher Education and Research
1 shared publication- Kodaganur Srinivaschar Gopinath
Healthcare Global Enterprises Ltd., Bangalore, India
1 shared publication Suma Mysore Narayana
Kidwai Memorial Institute of Oncology
1 shared publication- Tn Suresh
Sri Devaraj Urs Medical College
1 shared publication
Latest Publications
- 2 July 2026
- Published by Springer Nature in Oral and Maxillofacial Surgery
- Vol. 30 (1)
Health adjusted age and surgical outcomes in elderly oral cavity cancer patients: a case series from the Indian subcontinent
Elderly oral cavity cancer patients form a unique cohort with multiple therapeutic considerations. The Oral Cancer Survival Calculator® has been used to estimate the risk of cancer-specific deaths in patients with oral cancer. The aim of our study was to evaluate surgical outcomes and cancer-specific survival in elderly oral cavity cancer patients using the calculator. Retrospective outcome analysis of elderly (>/=70 years) oral cavity cancer patients undergoing surgery at a rural-based tertiary academic institution was performed. The calculator was used to decipher health adjusted age (HAA), estimated 1-, 2- and 5-year overall survival (OS) and cancer specific deaths. Chronological age and HAA-related outcomes were analysed. Ninety-seven elderly patients (median age: 74 years) underwent surgery. Post-operative complications were noted in 18.6%, with an overall mortality of 14.4%. Presence of comorbidities (p < 0.001) and the need for tracheostomy (p < 0.001) significantly increased complication rates. Using the calculator, the estimated 1-, 2- and 5-year OS and cancer-related deaths was 84%, 71% and 37% and 14%, 26% and 37% respectively. However, the accuracy of the calculator in predicting deaths was 55.5%. HAA, obtained from the calculator, was lower than the corresponding chronological age in 57.7% of patients and was associated with lower post-operative complications (7.1%) and re-admission (1.8%) rates. HAA was predictive of lower complication and re-admission rates after surgery in elderly oral cavity cancer patients. The Oral Cancer Survival Calculator ® showed a moderate prediction for mortality. However, larger studies are needed to validate these findings.
- 2 July 2026
- Published by Springer Nature in Oral and Maxillofacial Surgery
- Vol. 30 (1)
Health adjusted age and surgical outcomes in elderly oral cavity cancer patients: a case series from the Indian subcontinent
Elderly oral cavity cancer patients form a unique cohort with multiple therapeutic considerations. The Oral Cancer Survival Calculator® has been used to estimate the risk of cancer-specific deaths in patients with oral cancer. The aim of our study was to evaluate surgical outcomes and cancer-specific survival in elderly oral cavity cancer patients using the calculator. Retrospective outcome analysis of elderly (>/=70 years) oral cavity cancer patients undergoing surgery at a rural-based tertiary academic institution was performed. The calculator was used to decipher health adjusted age (HAA), estimated 1-, 2- and 5-year overall survival (OS) and cancer specific deaths. Chronological age and HAA-related outcomes were analysed. Ninety-seven elderly patients (median age: 74 years) underwent surgery. Post-operative complications were noted in 18.6%, with an overall mortality of 14.4%. Presence of comorbidities (p < 0.001) and the need for tracheostomy (p < 0.001) significantly increased complication rates. Using the calculator, the estimated 1-, 2- and 5-year OS and cancer-related deaths was 84%, 71% and 37% and 14%, 26% and 37% respectively. However, the accuracy of the calculator in predicting deaths was 55.5%. HAA, obtained from the calculator, was lower than the corresponding chronological age in 57.7% of patients and was associated with lower post-operative complications (7.1%) and re-admission (1.8%) rates. HAA was predictive of lower complication and re-admission rates after surgery in elderly oral cavity cancer patients. The Oral Cancer Survival Calculator ® showed a moderate prediction for mortality. However, larger studies are needed to validate these findings.
- 24 December 2025
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (4) , 976-982
Primary Uterine Alveolar Rhabdomyosarcoma: A Rare Entity
Primary alveolar rhabdomyosarcoma arising in the uterus is an extremely uncommon entity and is often a diagnosis of exclusion. Rapid uterine enlargement and per-vaginal bleeding are the commonest clinical presentations of this tumour. In the absence of such symptoms, diagnostic delays are not uncommon. An elderly woman presented with abdominal distention and weight loss of 12 months duration with no prior gynaecological symptoms. Imaging showed a large, heterogeneous uterine mass reaching up to the epigastrium, with no evidence of distant metastases. An image-guided biopsy suggested a high-grade sarcoma. She underwent standard surgical staging, which included total abdominal hysterectomy, bilateral salphingo-oophorectomy and pelvic lymphadenectomy. The histopathological examination and immunohistochemical studies established the diagnosis of a primary uterine rhabdomyosarcoma, which was later confirmed to be of the alveolar subtype by a positive translocation of the FOXO1 gene on fluorescence in situ hybridization. Primary uterine alveolar rhabdomyosarcoma is rare in adults. The immunohistochemistry and translocation studies are important to establish the diagnosis, especially when presenting symptoms are non -specific.
- 24 December 2025
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (4) , 976-982
Primary Uterine Alveolar Rhabdomyosarcoma: A Rare Entity
Primary alveolar rhabdomyosarcoma arising in the uterus is an extremely uncommon entity and is often a diagnosis of exclusion. Rapid uterine enlargement and per-vaginal bleeding are the commonest clinical presentations of this tumour. In the absence of such symptoms, diagnostic delays are not uncommon. An elderly woman presented with abdominal distention and weight loss of 12 months duration with no prior gynaecological symptoms. Imaging showed a large, heterogeneous uterine mass reaching up to the epigastrium, with no evidence of distant metastases. An image-guided biopsy suggested a high-grade sarcoma. She underwent standard surgical staging, which included total abdominal hysterectomy, bilateral salphingo-oophorectomy and pelvic lymphadenectomy. The histopathological examination and immunohistochemical studies established the diagnosis of a primary uterine rhabdomyosarcoma, which was later confirmed to be of the alveolar subtype by a positive translocation of the FOXO1 gene on fluorescence in situ hybridization. Primary uterine alveolar rhabdomyosarcoma is rare in adults. The immunohistochemistry and translocation studies are important to establish the diagnosis, especially when presenting symptoms are non -specific.